REVIEW ARTICLE e-ISSN: 2349-0659 p-ISSN; 2350-0964 Characterization of Impurities in Reverse Transcriptase Inhibitors by Profling Techniques Ashwini V. Shelke 1,2 *, Tushar N. Lokhande 1 , Vaishali Pardeshi 1 , Kavita Daware 1 , Shweta Jadhav 1 , Anil Jadhav 1 A BSTRACT There has been ever growing activity in impurities existing in pharmaceutical products as well as bulk drugs. According to a range of regulatory authorities, no longer solely purity profles, however additionally impurity profles, are now required. The technique facts for an individual impurity’s organic safety are recognized as impurity profling. The many developments in analytical viewpoints of impurity profling of anti-retroviral (ARV) medicines and products used to deal with human immunodefciency virus (HIV) infections are described in this review. ARVs work using inhibiting unique ranges of the viral contamination cycle to produce therapeutic benefts. Thus, drug classes are stratifed as nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs/NTRTIs), non-NRTIs (NNRTIs), integrase strand transfer inhibitors, CCR5 antagonists, viral fusion inhibitors, and protease inhibitors (PIs). In this overview predominant focal point given on class that is reverse transcriptase inhibitors (RTIs). The wide variety of papers dealing with ARV drug impurity profling is developing at an alarming pace. The cutting-edge overview article, which is based primarily on publications posted in the closing 15 years, tries to provide vast data concerning RTIs drug impurity profling. RTIs which are labeled into two sub-categories, that is, NRTIs and NNRTIs. NRTIs pressure the HIV virus to use erroneous variations of building block, so contaminated cells cannot make more HIV and NNRTIs these are additionally referred to as “non- nukes.” NNRTIs bind to a precise protein so the HIV virus cannot make copies of itself. The investigatory overview might also furnish the complete important points to the researchers who are working in the region of impurity profling of RTIs. To the most tremendous of our information, no overview until date noted to center of attention on impurity profling of RTIs. Keywords: Anti-retroviral drugs, HIV, Impurity profling, International council for harmonization guidelines, Reverse transcriptase inhibitors, HIV Asian Pac. J. Health Sci., (2022); DOI: 10.21276/apjhs.2022.9.4S.06 ©2022 The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. I NTRODUCTION The primary intention of bulk drug industries and pharmaceutical industries is to produce the high-quality excellent product. The drugs are intended for saving lives in which even minute quantities of impurities are unacceptable. Hence, impurity profiling has obtain very importance. [1] The “International Council for Harmonization and Technical Requirements for Pharmaceuticals for use of Human (ICH)” gives the following definitions for impurities and impurity profile in new remedy substances. [2] An impurity is “Any a section of the new drug substance that is not the chemical factor characterized as the new drug substance.” An impurity profile is “A depiction of the diagnosed and unrecognized impurities existing in a new drug substance.” Analytical things to do for the detection, identification/structure elucidation, and quantitative determination of natural and inorganic impurities, as properly as residual solvents in bulk drugs and pharmaceutical formulations, are referred to as impurity profiling. [3] The value of drug impurity profiling is that it presents facts that can at once lead to drug therapy safety using decreasing impurity-related detrimental results of drug substances and preparations. [4] The pharmacological–toxicological profile of a drug, as nicely as the adverse outcomes brought about through impurities in bulk and dosage types, decide its safety, that is, the security of a drug product is decided no longer only by the toxicological properties of the active drug material itself, however additionally by means of the impurities that it contains. Another factor to think about is that the components need to keep its identity, strength, purity, and consistency all through the product’s shelf life. Impurities in prescription drugs have to be monitored from the very starting, that is, from raw substances to the stop, that is, finished product, consisting of marketing survey. [5] The 1 Department of Pharmaceutical Chemistry, Mahatma Gandhi Vidya Mandir’s College of Pharmacy, Nashik, Maharashtra, India 2 Department of Pharmaceutical Chemistry, Sandip Institute of Pharmaceutical Sciences, Nashik, Maharashtra, India Corresponding Author: Ashwini V. Shelke, Mahatma Gandhi Vidya Mandir’s College of Pharmacy, Nashik, Maharashtra, India. E-mail: shelke.ashwini2@gmail.com How to cite this article: Shelke AV, Lokhande TN, Pardeshi V, Daware K, Jadhav S, Jadhav A. Characterization of Impurities in Reverse Transcriptase Inhibitors by ProflingTechniques. Asian Pac. J. Health Sci., 2022;9(4S):18-26. Source of support: Nil Conficts of interest: None. Received: 02/02/2022 Revised: 09/03/2022 Accepted: 30/04/2022 purpose of pharmaceutical impurity identification in the drug improvement phase is to completely elucidate the chemical structure of an unknown pharmaceutical impurity observed in both drug substances or drug merchandise above a particular threshold. [6] According to current estimates, 34 million individuals global are dwelling with human immunodefciency virus (HIV)/AIDS, with 2.5 million new infections taking place every year. [7] Infection- containing fuids, such as blood, breast milk, sperm, and vaginal secretions, are exchanged to spread the virus. [8-10] Sexual contact, injectable drug usage, transmission of contaminated physique fuids from mom to infant at some point of pregnancy, childbirth, or breast-feeding, and publicity of contaminated physique fuids to uncovered membranes or tissue are all feasible routes of viral infection. [10,11] Antiretroviral (ARV) remedy is the principal continue to be of HIV remedy and care, and it can drastically decrease HIV- related morbidity and mortality. [12-14] There are currently extra than